Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Chuanxinlian Tablets
- Development stage
- Unknown
- Lead developer
- Guangdong Xinfeng Pharmaceutical Industry
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Compound Chuanxinlian Tablets is a traditional Chinese medicine (TCM) oral tablet developed and manufactured by Guangdong Xinfeng Pharmaceutical. The formulation is a combination of two primary herbal ingredients: *Andrographis paniculata* (Chuanxinlian) and *Lubiancao* (Clerodendrum cyrtophyllum). It is indicated for clearing heat and detoxification, specifically for the treatment of wind-heat common colds, sore throats, and damp-heat diarrhea. As a traditional herbal compound, it provides anti-inflammatory and antimicrobial symptomatic relief without a single defined molecular target. The tablets are sugar-coated and are classified as an over-the-counter (OTC) Class A medicine in China under the approval number 国药准字Z44021273.
- Brand names
- 复方穿心莲片
- Other names
- Compound Chuanxinlian PianCompound Andrographis tablets
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)PPARG (Peroxisome proliferator-activated receptor gamma)SARS-CoV-2 spikeMpro (3C-like proteinase of SARS-CoV-2)SARS-CoV-2IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Compound Chuanxinlian Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Chuanxinlian Tablets.